Kytril

In the US, Kytril (granisetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative and Nausea/Vomiting - Radiation Induced.

US matches:

• Kytril


• Kytril Solution


• Kytril Tablets

UK matches:

• Kytril Ampoules 1mg/1ml (SPC)
• Kytril Infusion 3mg/3ml (SPC)
• Kytril Paediatric Liquid (SPC)
• Kytril Tablets 1mg and 2mg (SPC)

Ingredient matches for Kytril

Granisetron

Granisetron is reported as an ingredient of Kytril in the following countries:

• South Africa

Granisetron hydrochloride (a derivative of Granisetron) is reported as an ingredient of Kytril in the following countries:

• Algeria


• Argentina


• Aruba


• Australia


• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Canada


• Chile


• China


• Colombia


• Cote D'ivoire


• Croatia (Hrvatska)


• Cuba


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• Egypt


• Estonia


• Finland


• France


• Greece


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Iran


• Ireland


• Israel


• Italy


• Jamaica


• Japan


• Jordan


• Kenya


• Kuwait


• Latvia


• Lebanon


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mauritania


• Mexico


• Morocco


• Netherlands


• Oman


• Pakistan


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Korea


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Uruguay


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.